Understanding PI-QUAL for prostate MRI quality: a practical primer for radiologists.

Understanding PI-QUAL for prostate MRI quality: a practical primer for radiologists.
复制标题

DOI:
10.1186/s13244-021-00996-6
复制
发表时间:
2021-05-01
影响因子:
4.7
通讯作者:
Allen C
Allen C
中科院分区:
医学2区
文献类型:
--
作者:
Giganti F;Kirkham A;Kasivisvanathan V;Papoutsaki MV;Punwani S;Emberton M;Moore CM;Allen C

文献摘要

参考文献

被引文献

相似文献

高诊断质量的前列腺癌磁共振成像(MRI)是检测或排除前列腺癌的关键决定因素。高分辨率的T2加权成像、良好的扩散加权成像和高信噪比的动态增强序列是高质量的前列腺MRI研究的前提。前列腺成像质量(PI-QUAL)评分是根据前列腺成像-报告和数据系统建议以及从图像获得的标准来评估扫描的诊断质量的一组客观标准。PI-QUAL评分为1至5级,其中1分表示所有MR序列(T2加权成像、扩散加权成像和动态对比增强序列)均低于最低诊断质量标准,3分表示扫描具有足够的诊断质量,5分表示所有三种序列均具有最佳诊断质量。这篇教育综述的目的是为使用PI-QUAL评估前列腺MRI的质量提供实用指南,并使放射科医生和所有参与前列腺MRI的人熟悉这一评分系统。文中还展示了各种图像,以说明不理想和良好的前列腺磁共振扫描之间的区别。
Prostate magnetic resonance imaging (MRI) of high diagnostic quality is a key determinant for either detection or exclusion of prostate cancer. Adequate high spatial resolution on T2-weighted imaging, good diffusion-weighted imaging and dynamic contrast-enhanced sequences of high signal-to-noise ratio are the prerequisite for a high-quality MRI study of the prostate. The Prostate Imaging Quality (PI-QUAL) score was created to assess the diagnostic quality of a scan against a set of objective criteria as per Prostate Imaging-Reporting and Data System recommendations, together with criteria obtained from the image. The PI-QUAL score is a 1-to-5 scale where a score of 1 indicates that all MR sequences (T2-weighted imaging, diffusion-weighted imaging and dynamic contrast-enhanced sequences) are below the minimum standard of diagnostic quality, a score of 3 means that the scan is of sufficient diagnostic quality, and a score of 5 implies that all three sequences are of optimal diagnostic quality. The purpose of this educational review is to provide a practical guide to assess the quality of prostate MRI using PI-QUAL and to familiarise the radiologist and all those involved in prostate MRI with this scoring system. A variety of images are also presented to demonstrate the difference between suboptimal and good prostate MR scans.
DOI: 10.1016/j.ejrad.2017.02.044
发表时间: 2017-05-01
影响因子: 3.3
作者:
Ullrich, T.;Quentin, M.;Schimmoeller, L.
通讯作者: Schimmoeller, L.
DOI: 10.1007/s00330-020-06929-z
发表时间: 2020-05-19
期刊: EUROPEAN RADIOLOGY
影响因子: 5.9
作者:
de Rooij, Maarten;Israel, Bas;Barentsz, Jelle O.
通讯作者: Barentsz, Jelle O.
DOI: 10.1056/nejmoa1801993
发表时间: 2018-05-10
期刊: The New England journal of medicine
影响因子: --
作者:
通讯作者: --
DOI: 10.1016/j.acra.2020.01.031
发表时间: 2021-03
期刊: Academic radiology
影响因子: 4.8
作者:
Sackett J;Shih JH;Reese SE;Brender JR;Harmon SA;Barrett T;Coskun M;Madariaga M;Marko J;Law YM;Turkbey EB;Mehralivand S;Sanford T;Lay N;Pinto PA;Wood BJ;Choyke PL;Turkbey B
通讯作者: Turkbey B
DOI: 10.1007/s00330-017-4940-7
发表时间: 2018-01-01
期刊: EUROPEAN RADIOLOGY
影响因子: 5.9
作者:
Ullrich, T.;Quentin, M.;Schimmoeller, L.
通讯作者: Schimmoeller, L.